MyFinsight
Home
About
Contact
Back
Income Statement
TNF Pharmaceuticals, Inc. (TNFA)
source: myfinsight.com
Download
Download image
Net loss
attributable to common...
-$2,772.564K
(73.19%↑ Y/Y)
Net loss
-$1,796.195K
(81.22%↑ Y/Y)
Preferred stock dividends
$976.369K
(25.60%↑ Y/Y)
Change in fair value of
derivatives liabilities
$19K
Interest and dividend
income
$57.575K
(172.25%↑ Y/Y)
Loss before income
tax
-$1,796.195K
(81.22%↑ Y/Y)
Total other
(income)/expense
$76.428K
(101.23%↑ Y/Y)
Change in fair value of
marketable securities
-$0.147K
Loss from operations
-$1,872.623K
(44.43%↑ Y/Y)
Administrative expenses
$894.297K
(-12.35%↓ Y/Y)
Research and development
expenses
$873.472K
(117.77%↑ Y/Y)
Stock based
compensation expenses
$104.854K
(-76.15%↓ Y/Y)
Back